In the field of diabetes, many breakthroughs have been made in the discovery of DYRK1A inhibitors, including harmine, 5-IT and GNF2877, which can significantly promote the proliferation of rodent and human β-cells. Here, DYRK1A is linked to diabetes mellitus.